Ryan Pruchnic
Directeur/Membre du Conseil chez LIPELLA PHARMACEUTICALS INC.
Fortune : - $ au 30/04/2024
Profil
Ryan Pruchnic has worked as an Independent Director at Lipella Pharmaceuticals, Inc. since 2021 and as a Managing Vice President at Cook MyoSite, Inc. since 2001.
He has an undergraduate and graduate degree from the University of Pittsburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Ryan Pruchnic
| Sociétés | Poste | Début |
|---|---|---|
| LIPELLA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/09/2021 |
Cook MyoSite, Inc.
 Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Corporate Officer/Principal | 01/01/2001 |
Formation de Ryan Pruchnic
| University of Pittsburgh | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIPELLA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cook MyoSite, Inc.
Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Technology Services |
